Press coverage about Vical (NASDAQ:VICL) has been trending somewhat positive on Tuesday, according to Accern Sentiment. The research group ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Vical earned a news sentiment score of 0.17 on Accern’s scale. Accern also assigned headlines about the biotechnology company an impact score of 46.503992714246 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Here are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:

A number of brokerages recently issued reports on VICL. HC Wainwright set a $9.00 price objective on Vical and gave the company a “buy” rating in a research note on Wednesday, August 9th. Ifs Securities restated an “outperform” rating on shares of Vical in a research note on Tuesday, August 8th. Finally, Rodman & Renshaw restated a “buy” rating and issued a $9.00 price objective on shares of Vical in a research note on Monday, June 12th.

Shares of Vical (NASDAQ:VICL) opened at 2.47 on Tuesday. The company’s market capitalization is $27.41 million. The stock’s 50 day moving average price is $2.61 and its 200 day moving average price is $2.35. Vical has a 12 month low of $2.05 and a 12 month high of $4.45.

Vical (NASDAQ:VICL) last announced its earnings results on Tuesday, August 8th. The biotechnology company reported ($0.30) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by $0.02. The firm had revenue of $3.42 million during the quarter, compared to analysts’ expectations of $3.35 million. Vical had a negative return on equity of 26.09% and a negative net margin of 92.02%. On average, analysts forecast that Vical will post ($1.05) EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Vical (NASDAQ:VICL) Share Price” was originally published by Watch List News and is the property of of Watch List News. If you are viewing this news story on another site, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this news story can be viewed at

Vical Company Profile

Insider Buying and Selling by Quarter for Vical (NASDAQ:VICL)

Receive News & Ratings for Vical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vical Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.